Mark Flather | Vice President of Investor Relations |
Shawn Singh | Chief Executive Officer |
Jerry Dotson | Chief Financial Officer |
Mark Smith | Chief Medical Officer |
Brian Skorney | Robert W. Baird |
Tim Lugo | William Blair |
Jason McCarthy | Maxim Group |
Andrew Tsai | Jefferies |
Greetings, and welcome to VistaGen Therapeutic Second Quarter of Fiscal Year 2022 Results Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host Mark Flather, Vice President of Investor Relations.